肝硬化
超重
医学
肥胖
内科学
体质指数
瞬态弹性成像
肝病
胃肠病学
脂肪肝
前瞻性队列研究
队列
疾病
肝纤维化
作者
Alexander H. Yang,Monica A. Tincopa,Federica Tavaglione,Veeral H. Ajmera,Lisa Richards,Maral Amangurbanova,Christian H. Butcher,Christie Hernandez,Egbert V. Madamba,Seema Singh,Ricki Bettencourt,Bernd Schnabl,Claude B. Sirlin,Rohit Seth Loomba
出处
期刊:Gut
[BMJ]
日期:2024-08-07
卷期号:73 (12): 2045-2053
被引量:70
标识
DOI:10.1136/gutjnl-2024-332917
摘要
BACKGROUND: There are limited prospective data among overweight and obese individuals on the prevalence of advanced fibrosis, and cirrhosis using advanced MRI-based methods in the USA. The aim of this study was to fill that gap in knowledge by prospectively determining the MRI-based prevalence of steatotic liver disease (SLD) and its subcategories, advanced fibrosis and cirrhosis among overweight and obese individuals residing in the USA. METHODS: This is a cross-sectional analysis of prospectively enrolled overweight or obese adults aged 40-75 years from primary care and community-based settings in Southern California. Participants were classified as having SLD if MRI proton density fat fraction ≥5%, and subclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-related liver disease (ALD) consistently with the new nomenclature guidance per AASLD-EASL-ALEH. Advanced fibrosis and cirrhosis were defined as magnetic resonance elastography (MRE) ≥3.63 kPa and MRE ≥4.67 kPa, respectively. RESULTS: , respectively. The prevalence of SLD, advanced fibrosis and cirrhosis was 75%, 10.8% and 4.5%, respectively. The prevalence of MASLD, MetALD and ALD was 67.3%, 4.8% and 2.6%, respectively. There was no difference in prevalence of advanced fibrosis and cirrhosis among subcategories. CONCLUSIONS: Using advanced MRI methods among community-dwelling overweight and obese adults, the prevalence of cirrhosis was 4.5%. Most common SLD subcategory was MASLD with 67% of individuals, whereas MetALD and ALD were less common. Systematic screening for advanced fibrosis among overweight/obese adults may be considered.
科研通智能强力驱动
Strongly Powered by AbleSci AI